Gossamer Bio, Inc. (GOSS) stock
GOSSNasdaqPharmaceutical PreparationsFiscal year ends December 31
$10.97−0.27 (-2.40%)
Close on Nov 13, 2026Market cap $67.10MP/E –Yield –
Gossamer Bio profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Gossamer Bio's profit margin for the twelve months ending Sep 30, 2026 was -159.5%. For fiscal 2025 it was -351.5%, against -49.3% the year before.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -351.5% | −302.2 |
| FY2024 | Dec 31, 2024 | -49.3% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -125.1% | +237.6 |
| Q2 FY2026 | Jun 30, 2026 | 182.9% | +516.1 |
| Q1 FY2026 | Mar 31, 2026 | -275.2% | +95.3 |
| Q4 FY2025 | Dec 31, 2025 | -342.3% | +9.8 |
| Q3 FY2025 | Sep 30, 2025 | -362.7% | −37.8 |
| Q2 FY2025 | Jun 30, 2025 | -333.1% | −384.5 |
| Q1 FY2025 | Mar 31, 2025 | -370.5% | – |
| Q4 FY2024 | Dec 31, 2024 | -352.2% | – |
| Q3 FY2024 | Sep 30, 2024 | -324.9% | – |
| Q2 FY2024 | Jun 30, 2024 | 51.4% | – |
See a number that looks wrong?